SynthesisEuropean radiology2025
Availability and transparency of artificial intelligence models in radiology: a meta-research study.
Synthesis in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- OpenRad: a curated repository of open-access AI models for radiology.European radiology · 2026Article
- Leading Towards a Translation Readiness Framework: A Systematic Review of Deep Learning Approaches for Eye Disease Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
- Towards an accessible, centralised, searchable database for AI courses in Europe: the Artificial Intelligence in Medical Imaging and Radiation Oncology Education (AIMIROE) project.European radiology experimental · 2026Article
- Considering the missing science of retraining and maintenance in medical artificial intelligence, using ophthalmology as an exemplar.NPJ digital medicine · 2026Review
- Comparative Analysis of LLMs in Dry Eye Syndrome Healthcare Information.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesThis meta-research study explored the availability of artificial intelligence (AI) models from development studies published in leading radiology journals in 2022, with availability defined as the transparent reporting of relevant technical details, such as model architecture and weights, necessary for independent replication. MATERIALS AND
methodsA systematic search of Ovid Medline and Embase was conducted to identify AI model development studies published in five leading radiology journals in 2022. Data were extracted on study characteristics, model details, and code and model-sharing practices. The proportion of AI studies sharing their models was analyzed. Logistic regression analyses were employed to explore associations between study characteristics and model availability.
resultsOf 268 studies reviewed, 39.9% (n = 107) made their models available. Deep learning (DL) models exhibited particularly low availability, with only 11.5% (n = 13) of the 113 studies being fully available. Training codes for DL models were provided in 22.1% (n = 25), suggesting limited ability to train DL models with one's own data. Multivariable logistic regression analysis showed that the use of traditional regression-based models (odds ratio [OR], 17.11; 95% CI: 5.52, 53.05; p < 0.001) was associated with higher availability, while the radiomics package usage (OR, 0.27; 95% CI: 0.11, 0.65; p = 0.003) was associated with lower availability.
conclusionThe availability of AI models in radiology publications remains suboptimal, especially for DL models. Enforcing model-sharing policies, enhancing external validation platforms, addressing commercial restrictions, and providing demos for commercial models in open repositories are necessary to improve transparency and replicability in radiology AI research. KEY POINTS: Question The study addresses the limited availability of AI models in radiology, especially DL models, which impacts external validation and clinical reliability. Findings Only 39.9% of radiology AI studies made their models available, with DL models showing particularly low availability at 11.5%. Clinical relevance Improving the availability of radiology AI models is essential for enabling external validation, ensuring reliable clinical application, and advancing patient care by fostering robust and transparent AI systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.